An Integrated Community-based Intervention Package in Improving Maternal and Neonatal Health Outcomes (ICBIP-MNH))

Effectiveness of an Integrated Community-based Intervention Package in Improving Maternal, and Neonatal Health Outcome in Jimma Zone, Southwest Ethiopia: a Cluster Randomized Controlled Trial

This study aims to improve maternal, neonatal and infant health outcomes through an integrated community-based intervention package in Jimma Zone, Southwest Ethiopia.

Study Overview

• Status: Recruiting
• Conditions: Knowledge, Attitudes, Practice; Morbidity;Newborn; Breastfeeding, Exclusive; Complementary Feeding; Food Security; Integrated Community-based Intervention Package; Birth Preparedness and Complication Readiness Plan; Neonatal Care; Health Care Seeking Behavior; Delivery Care; Postnatal Care
• Intervention / Treatment: Behavioral: Behaviour Change Communication and Male involvement intervention

Detailed Description

Background: Maternal, newborn, infant's morbidity and mortality are unacceptably high in sub-Saharan Africa including Ethiopia. Despite considerable efforts made in maternal and child health care, poor maternal, neonatal and child health problems remained a significant public health concern globally and particularly in low and middle-income countries. Community-based Interventions and strategies for improving maternal, newborn, and child health care have been recommended through a continuum of care approach. However, few efforts have been made to identify synergies and integrate different intervention packages across the country.

Objective: This study aims to assess the effectiveness of an integrated community-based intervention package in improving maternal, neonatal and infant health outcomes in Jimma Zone, Southwest Ethiopia: a cluster randomized controlled trial.

Methods: This is a parallel-arm, single-blind, cluster randomized controlled trial conducted in the Dedo and Seka Chekorsa districts of the Jimma zone. After excluding 10 kebeles from each district to be considered as a buffer zone, we will assign 26 kebeles to the intervention arm and 26 to the control arm. A total of 624 pregnant women in their third trimester who reside in the kebeles assigned to the intervention clusters will be identified and enrolled (312 in intervention and 312 in control groups). The intervention includes Behavioral Change Communication, and male involvement. Various multidisciplinary professionals and experts regularly monitor the overall process of the research and intervention activities. The effect of the intervention in comparison with the routine care will be assessed by fitting mixed-effects linear regression models for the continuous outcomes and mixed-effects linear probability models for the binary outcomes. In all analyses, adjustment will be made for clustering at the kebele level and covariate. All tests will be two-sided and the level of significance will be set at alpha < 0.05.

Budget: A total of 579,888.4ETB will be required. Key words: community-based intervention, maternal, neonatal, infant, health outcome, randomized controlled trial

• Study Type: Interventional
• Enrollment (Anticipated): 624
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Bekelu Teka, MPH; Phone Number: +251 945 031 001; Email: bekelut23@gmail.com
• Study Contact Backup: Name: Misra Abdulahi, MPH; Phone Number: +251912010293; Email: misra_ab@yahoo.com

Study Locations

• Ethiopia
  • Oromia
    • Jimma, Oromia, Ethiopia, 378
      • Recruiting
      • Jimma University
      • Contact: Jimma University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 15 years to 49 years (Child, Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Pregnant women in the third trimester
• Live in the selected cluster

Exclusion Criteria:

• Serious illness or clinical complications requiring hospitalization
• Maternal death
• Newborn death
• Stillbirth
• Twin gestation
• Preterm birth (at <37 weeks)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention group; An integrated Community-based package of interventions An integrated intervention consisting of behaviourchange communication, and male involvement will be delivered to pregnant women in their third trimester. They will receive 2 prenatal and five home visits. each visit will last 40-60 minutes. After delivery mother-newborn pairs will be followed up until six weeks.	Behavioral: Behaviour Change Communication and Male involvement intervention; For the integration of the intervention, it is planned to deliver both service at the same time a by the same means to the women and the men. Pregnant women who fail to take one of the intevetion will not be considered as the participant who received integrated intervention. The intervention will be provided through Women Developmental army (WDA) leaders imparted through gatherings and home visits whereas the Broadcast will be used to strengthen and as a frequent remidinng of the conveyed messages.; Other Names: BCC
No Intervention: Control group; First, we selected two districts that have similar characteristics and are adjacent to each other. Both districts have a total of 72 kebeles (the smallest administrative unit), 36 in each district. Then, we chose 20, 10 from each district, kebeles on the boundary of the two districts to act as a buffer zone, to prevent information contamination between the intervention and control clusters. Finally, 26 kebeles in the Dedo district will be assigned to the intervention group while 26 kebeles in the Seka Chekorsa district are assigned to control clusters. Allocation concealment will not be done for study participants, as they would certainly know if they are in the intervention group or not. However, data collectors will be blinded to the allocation assignment by not being informed about it, not being part of the trial implementers, and not being inhabitants of any of the kebeles. Moreover, data analysts will be blinded to group allocation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neonatal care practices	Prevalence of neonatal care practices	At month one after delivery
Feeding practice	prevalence of early initiation and exclusive breastfeeding	At month one after delivery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Neonatal morbidity	Prevalence of neonatal morbidity	At month one after delivery
Maternal morbidity	Prevalence of maternal morbidity	At month one after delivery
Birth preparedness and complication readiness plan	Proportion of women who had Birth preparedness and complication readiness plan	At month one after delivery
Maternal feeding practice	Prevalence of minimum dietary diversity	: At month one after delivery
Skilled delivery	Prevalence of women who delivered at health institution	At month one after delivery

Collaborators and Investigators

• Sponsor: Jimma University
• Investigators: Principal Investigator: Bekelu Teka, MPH, Jimma University

Study record dates

Study Major Dates

• Study Start (Actual): August 20, 2022
• Primary Completion (Anticipated): April 20, 2023
• Study Completion (Anticipated): September 20, 2023

Study Registration Dates

• First Submitted: August 24, 2022
• First Submitted That Met QC Criteria: August 24, 2022
• First Posted (Actual): August 26, 2022

Study Record Updates

• Last Update Posted (Estimate): March 10, 2023
• Last Update Submitted That Met QC Criteria: March 8, 2023
• Last Verified: March 1, 2023

More Information

Terms related to this study

• Keywords: randomized controlled trial; community-based intervention,; maternal,; neonatal,; infant,; health outcome,
• Other Study ID Numbers: JUIH/IRB/110/22

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No